Compare INO & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INO | BYRN |
|---|---|---|
| Founded | 1979 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 136.3M |
| IPO Year | 1999 | 2013 |
| Metric | INO | BYRN |
|---|---|---|
| Price | $1.18 | $6.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $6.75 | ★ $23.17 |
| AVG Volume (30 Days) | ★ 3.7M | 382.3K |
| Earning Date | 05-08-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $42,220,086.00 | $16,566,295.00 |
| Revenue This Year | $20,156.19 | $4.98 |
| Revenue Next Year | $421.95 | $16.86 |
| P/E Ratio | ★ N/A | $200.67 |
| Revenue Growth | 19.37 | ★ 1692.08 |
| 52 Week Low | $1.03 | $4.84 |
| 52 Week High | $2.86 | $33.56 |
| Indicator | INO | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 54.41 |
| Support Level | $1.03 | $5.56 |
| Resistance Level | $1.23 | $6.80 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | -0.01 | 0.19 |
| Stochastic Oscillator | 12.50 | 73.02 |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.